Streetbeat News

Analyst Ratings

LOW

Lowe's Companies's (NYSE:LOW) short percent of float has fallen 12.11% since its last report, with 11.46 million shares sold short, which is 1.96% of all regular shares available for trading. This decrease in short interest could indicate a more bullish market sentiment towards Lowe's. Compared to its peers, Lowe's has less short interest as a percentage of float, with an average of 19.16%.

Portfolio Pulse from Benzinga Insights

July 11, 2023 | 1:01 pm

BX

Over the past 3 months, 12 analysts have published their opinion on Blackstone (NYSE:BX) stock. The average 12-month price target for Blackstone has increased by 0.82% from the previous average price target of $98.90 to $99.71. The high price target is $111.00 and the low is $70.50.

Portfolio Pulse from Benzinga Insights

July 11, 2023 | 1:01 pm

UNH

UnitedHealth Group (NYSE:UNH) has received 19 analyst ratings in the last quarter, all of which are bullish or somewhat bullish. The average price target is $589.74, representing an upside from the current price of $463.05. This average is a 2.22% decrease from the previous average price target of $603.11.

Portfolio Pulse from Benzinga Insights

July 11, 2023 | 1:00 pm

GNRC

Argus Research analyst John Eade has upgraded Generac Hldgs (NYSE:GNRC) from Hold to Buy and set a price target of $155.

Portfolio Pulse from richadhand@benzinga.com

July 11, 2023 | 1:00 pm

PAYO

Analysts have given Payoneer Global (NASDAQ:PAYO) mostly bullish ratings in the last quarter, with an average price target of $8.5, indicating potential upside from the current price of $4.83. However, this average has decreased by 15.0% from the previous average price target of $10.00.

Portfolio Pulse from Benzinga Insights

July 11, 2023 | 1:00 pm

BIIB

Morgan Stanley analyst Matthew Harrison has maintained an Overweight rating on Biogen (NASDAQ:BIIB) but lowered the price target from $371 to $355.

Portfolio Pulse from Benzinga Newsdesk

July 11, 2023 | 12:58 pm

FOLD

Morgan Stanley analyst Andrew Galler has reiterated an Equal-Weight rating on Amicus Therapeutics (NASDAQ:FOLD) and maintained a $15 price target.

Portfolio Pulse from Benzinga Newsdesk

July 11, 2023 | 12:57 pm

AES

Barclays analyst Stephen Byrd has maintained an Overweight rating on AES (NYSE:AES) but lowered the price target from $31 to $29.

Portfolio Pulse from Benzinga Newsdesk

July 11, 2023 | 12:54 pm

ADCT

Morgan Stanley analyst Matthew Harrison has reiterated an Equal-Weight rating on ADC Therapeutics (NYSE:ADCT) and maintained a $5 price target.

Portfolio Pulse from Benzinga Newsdesk

July 11, 2023 | 12:50 pm

CFG

CMA

TWO

Three high-yielding dividend stocks in the financial sector have been highlighted by Wall Street's most accurate analysts. These include Two Harbors Investment Corp. (TWO), Citizens Financial Group, Inc. (CFG), and Comerica Incorporated (CMA). Recent news for each company includes weaker-than-expected Q1 earnings for TWO, upcoming Q2 earnings for CFG, and Comerica Bank being named to DiversityInc's 2023 Top Noteworthy Companies.

Portfolio Pulse from Lisa Levin

July 11, 2023 | 12:48 pm